Jennifer Buell

CIK 1711184 · See Remarks · last filed 2026-04-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$761.6K

Companies

3

Total Filings

35

Lifetime Open-Market Net

-$12.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGEN See Remarks 19,738 $3.30 $65.1K -$12.2K 23 2026-04-28
INKT Chief Executive Officer 57,942 $12.02 $696.5K $0 10 2026-01-14
Protagenic Therapeutics, Inc.\new (PTIXW) Delisted Director $0.01 $0 1 2024-03-29

Recent Filings · Page 2 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-03-11 AGEN Grant (A) +545 $1.8K EDGAR
2025-03-05 AGEN Grant (A) +626 $2.1K EDGAR
2025-02-18 AGEN Grant (A) +516 $1.8K EDGAR
2025-02-04 AGEN Tax (F) −270 -$964 EDGAR
2025-01-28 AGEN Grant (A) +776 $2.8K EDGAR
2024-11-18 AGEN Grant (A) $0 EDGAR
2024-03-29 Protagenic Therapeutics, Inc.\new (PTIXW) Delisted Grant (A) $0 EDGAR
2024-01-18 INKT Grant (A) $0 EDGAR
2023-10-13 INKT Mixed −695,750 $0 EDGAR
2023-10-03 INKT Tax (F) −148,550 -$151.4K EDGAR
Showing 1120 of 35
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.